Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Goemaere

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
The Journal of Antimicrobial Chemotherapy|December 22, 2007
Effect of rifampicin-based antitubercular therapy on nevirapine plasma concentrations in South African adults with HIV-associated tuberculosisKaren Cohen, Gilles van Cutsem, Andrew Boulle, et al.
Plos One|March 8, 2011
Correcting for mortality among patients lost to follow up on antiretroviral therapy in South Africa: a cohort analysisGilles Van Cutsem, Nathan Ford, Katherine Hildebrand, et al.
Plos One|October 17, 2012
The effect of complete integration of HIV and TB services on time to initiation of antiretroviral therapy: a before-after studyBernhard Kerschberger, Katherine Hilderbrand, Andrew M Boulle, et al.
Journal of the International AIDS Society|September 26, 2015
Superior virologic and treatment outcomes when viral load is measured at 3 months compared to 6 months on antiretroviral therapyBernhard Kerschberger, Andrew M Boulle, Katharina Kranzer, et al.
AIDS (London, England)|April 3, 2004
Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South AfricaDavid Coetzee, Katherine Hildebrand, Andrew Boulle, et al.
AIDS (London, England)|October 29, 2010
Early initiation of antiretroviral therapy and associated reduction in mortality, morbidity and defaulting in a nurse-managed, community cohort in LesothoNathan Ford, Katharina Kranzer, Katherine Hilderbrand, et al.
Plos One|March 17, 2011
Renal safety of a tenofovir-containing first line regimen: experience from an antiretroviral cohort in rural LesothoHelen Bygrave, Katharina Kranzer, Katherine Hilderbrand, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 8, 2018
The Continuing Burden of Advanced HIV Disease Over 10 Years of Increasing Antiretroviral Therapy Coverage in South AfricaMeg Osler, Katherine Hilderbrand, Eric Goemaere, et al.
JAMA|August 5, 2008
Outcomes of nevirapine- and efavirenz-based antiretroviral therapy when coadministered with rifampicin-based antitubercular therapyAndrew Boulle, Gilles Van Cutsem, Karen Cohen, et al.
Lancet (London, England)|August 25, 2025
Upholding medical ethics: a letter to the Israeli Medical AssociationLeon Geffen, Mitch Besser, Eric Goemaere, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
The Journal of Antimicrobial Chemotherapy|December 22, 2007
Effect of rifampicin-based antitubercular therapy on nevirapine plasma concentrations in South African adults with HIV-associated tuberculosisKaren Cohen, Gilles van Cutsem, Andrew Boulle, et al.
Plos One|March 8, 2011
Correcting for mortality among patients lost to follow up on antiretroviral therapy in South Africa: a cohort analysisGilles Van Cutsem, Nathan Ford, Katherine Hildebrand, et al.
Plos One|October 17, 2012
The effect of complete integration of HIV and TB services on time to initiation of antiretroviral therapy: a before-after studyBernhard Kerschberger, Katherine Hilderbrand, Andrew M Boulle, et al.
Journal of the International AIDS Society|September 26, 2015
Superior virologic and treatment outcomes when viral load is measured at 3 months compared to 6 months on antiretroviral therapyBernhard Kerschberger, Andrew M Boulle, Katharina Kranzer, et al.
AIDS (London, England)|April 3, 2004
Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South AfricaDavid Coetzee, Katherine Hildebrand, Andrew Boulle, et al.
AIDS (London, England)|October 29, 2010
Early initiation of antiretroviral therapy and associated reduction in mortality, morbidity and defaulting in a nurse-managed, community cohort in LesothoNathan Ford, Katharina Kranzer, Katherine Hilderbrand, et al.
Plos One|March 17, 2011
Renal safety of a tenofovir-containing first line regimen: experience from an antiretroviral cohort in rural LesothoHelen Bygrave, Katharina Kranzer, Katherine Hilderbrand, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 8, 2018
The Continuing Burden of Advanced HIV Disease Over 10 Years of Increasing Antiretroviral Therapy Coverage in South AfricaMeg Osler, Katherine Hilderbrand, Eric Goemaere, et al.
JAMA|August 5, 2008
Outcomes of nevirapine- and efavirenz-based antiretroviral therapy when coadministered with rifampicin-based antitubercular therapyAndrew Boulle, Gilles Van Cutsem, Karen Cohen, et al.
Lancet (London, England)|August 25, 2025
Upholding medical ethics: a letter to the Israeli Medical AssociationLeon Geffen, Mitch Besser, Eric Goemaere, et al.
Pageof 6